345.25 9.05 (2.69%)

13,849 NSE+BSE Volume

NSE 19 Mar, 2025 3:52 PM (IST)



Board Meetings - Kilitch Drugs(I) Ltd.

The latest board meeting for Kilitch Drugs(I) Ltd. took place on 11 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
11 Feb 2025 Quarterly Results -
12 Nov 2024 Quarterly Results -
08 Aug 2024 Quarterly Results -
27 May 2024 Quarterly Results -
08 Feb 2024 Quarterly Results -
09 Nov 2023 Quarterly Results -
11 Aug 2023 Quarterly Results -
22 Jul 2023 Others To consider and approve conversion of warrants into the equity shares of the Company to the specified person only.
29 May 2023 Audited Results -
14 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
10 Aug 2022 Quarterly Results -
26 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
12 Nov 2021 Quarterly Results -
13 Aug 2021 Quarterly Results -
22 Jun 2021 Audited Results -
11 Feb 2021 Quarterly Results -
13 Nov 2020 Quarterly Results -
15 Sep 2020 Quarterly Results -
28 Aug 2020 Others -
30 Jun 2020 Audited Results -
25 May 2020 Others Inter alia, to consider and approve the allotment of Equity Shares pursuant to exercise of option granted to employees of the Company under ESOS Scheme.
14 Feb 2020 Quarterly Results & Others -
12 Dec 2019 Others Inter alia, to consider and approve the proposal for investing in setting up of new green field project in Ethiopia.
13 Nov 2019 Quarterly Results -
19 Sep 2019 Quarterly Results inter alia, to consider and approve un-audited consolidated financial results of the company for the quarter ended June 30th, 2019.
22 Aug 2019 Others -
13 Aug 2019 Quarterly Results -
30 May 2019 Audited Results & Dividend -
03 May 2019 Others Inter alia, to consider and approve the allotment of Equity Shares pursuant to exercise of option granted to employees of the Company under ESOS Scheme.
12 Feb 2019 Quarterly Results & Others -
07 Nov 2018 Quarterly Results & Others -
31 Aug 2018 Others To consider the conversion of 16,00,000 Warrants issued at a price of Rs. 59/- per warrant & allotment of 16,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants
13 Aug 2018 Quarterly Results & Others -
28 Jun 2018 Others To consider appointment of Shri Venkita Subramanian Rajan (DIN:00059146) as an Additional Director.
25 May 2018 Audited Results & Final Dividend -
29 Mar 2018 Others To consider the conversion of 5,00,000 Warrants issued at a price of Rs. 59/- per warrant and allotment of 5,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants
16 Mar 2018 Others To consider appointment of Additional Director.
14 Feb 2018 Quarterly Results -
14 Nov 2017 Quarterly Results -
20 Sep 2017 Others 1. To consider appointment of the Company Secretary and Compliance Officer of the Com. 2. To take note of the outgoing Company Secretary of the Company.
23 Aug 2017 Others To consider, adopt and approve the Notice of the 25th AGM along with all relevant annexure for financial year 2016-17.
14 Aug 2017 Quarterly Results -
25 Jul 2017 Others -
30 May 2017 Audited Results -
13 Feb 2017 Quarterly Results & Others To consider grant of additional options to the employees of the Company under ESOP Scheme.
14 Nov 2016 Quarterly Results -
12 Aug 2016 Quarterly Results -
30 May 2016 Audited Results -
11 Mar 2016 Others To consider entering into an Agreement with respect to capital contribution with Arham Neeta Realities LLP,.
12 Feb 2016 Quarterly Results Adoption of SEBI (Listing Obligations and Disclosure Requirements] Regulations, 2015.
11 Nov 2015 Quarterly Results -
14 Aug 2015 Quarterly Results -
28 May 2015 Audited Results -
27 Apr 2015 Appointment & Resignation of Director To consider and approve the terms of settlement arrived at by the Company with Aura Pharmaceuticals Inc.
14 Apr 2015 Appointment of Secretary & Others 1. To consider appointment of Scrutinizer to oversee the Postal Ballot process of the Company. 2. Approved the investment upto USD 200,000 (approx. INR 1,25,00,000/-) in KILITCH ESTRO BIOTECH PLC.
31 Mar 2015 Appointment of Director -
12 Feb 2015 Quarterly Results -
14 Nov 2014 Quarterly Results -
14 Aug 2014 Quarterly Results & Others To finalize the date venue and time for convening 22nd Annual General Meeting of the Members of the Company.
30 May 2014 Audited Results -
13 Feb 2014 Quarterly Results -
14 Nov 2013 Quarterly Results -
21 Oct 2013 Others To consider investment in other Body Corporate pursuant to all applicable provisions of the Companies Act, 1956.
17 Oct 2013 Appointment of Additional Director To consider appointment of Additional Director(s) on Board of the Company.
14 Aug 2013 Quarterly Results & Others -
30 May 2013 Audited Results -
12 Feb 2013 Quarterly Results -
15 Jan 2013 To consider Sale of Investments To consider sale of investments made by the Company.
09 Nov 2012 Quarterly Results -
30 Aug 2012 Audited Results & Sp. Interim Dividend 1. To take on record the Audited Consolidated Financial Results of the Company for the year ended March 31, 2012. 2. To adopt and approve the Notice & Directors Report of the Company.
09 Aug 2012 Quarterly Results -
14 May 2012 Quarterly Results -
06 Feb 2012 Quarterly Results -
14 Nov 2011 Quarterly Results -
12 Aug 2011 Quarterly Results -
25 Jul 2011 Audited Results, Dividend & Others -
14 May 2011 Quarterly Results -
14 Feb 2011 Quarterly Results & ESOP To consider allotment of Shares against exercise of employee stock option under ESOS KDL 2007 as approved by the Shareholders of the Company at their EGM held on May 31, 2010.
12 Nov 2010 Quarterly Results -
16 Oct 2010 Employees Stock Option Plan -
10 Aug 2010 Audited Results -
30 Jul 2010 Quarterly Results -
24 Apr 2010 Employees Stock Option Plan inter alia, to implement the ESOS Scheme as per SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 as amended.
30 Jan 2010 Quarterly Results -
30 Oct 2009 Quarterly Results -
31 Jul 2009 Quarterly Results -
30 Jun 2009 Audited Results & Dividend -
30 Jan 2009 Quarterly Results -
27 Oct 2008 Quarterly Results -
16 Sep 2008 To consider Allotment of Warrants To issue and allot of 29,00,000 Warrants at a price of Rs 120/- per share on preferential basis to selected persons / entities.
31 Jul 2008 Quarterly Results -
11 Jul 2008 To consider Issue of securities inter alia, to consider issue of securities to certain selected persons / entities, on preferential basis, subject to compliance of SEBI (Disclosure & Investor Protection) Guidelines, 2000.
30 Jun 2008 To appoint Additional Directors To appoint of Mr. Shailesh Chheda, Mr. Hemang Engineer, Mr. Deepak Shenoy & Dr. Mahalingam Vasudevan as Additional Directors.
21 Jun 2008 Audited Results & Final Dividend -
28 Jan 2008 Quarterly Results -
31 Oct 2007 Quarterly Results & Interim Dividend -
30 Jul 2007 Quarterly Results -
30 Jun 2007 Audited Results -